We report a novel ruthenium bis(pyrazolyl)borate scaffold that enables cooperative reduction reactivity in which boron and ruthenium centers work in concert to effect selective nitrile reduction. The pre-catalyst compound [κ(3)-(1-pz)2HB(N = CHCH3)]Ru(cymene)(+) TfO(-) (pz = pyrazolyl) was synthesized using readily-available materials through a straightforward route, thus making it an appealing...

The in vitro inter- and intra-cellular distribution of an isotopically labelled ruthenium(II)-arene (RAPTA) anti-metastatic compound in human ovarian cancer cells was imaged using nano-scale secondary ion mass spectrometry (NanoSIMS). Ultra-high resolution isotopic images of (13)C, (15)N, and Ru indicate that the phosphine ligand remains coordinated to the ruthenium(II) ion whereas the arene de...

A photolabile ruthenium-based complex, [Ru(bpy)2 (4AMP)2 ](PF6 )2 , (4AMP=4-(aminomethyl)pyridine) is incorporated into polyurea organo- and hydrogels via the reactive amine moieties on the photocleavable 4AMP ligands. While showing long-term stability in the dark, cleavage of the pyridine-ruthenium bond upon irradiation with visible or near-infrared irradiation (in a two-photon process) leads ...

We herein describe a systematic account of mononuclear ruthenium vinyl complexes L-{Ru}-CH=CH-R where the phosphine ligands at the (PR'3)2Ru(CO)Cl={Ru} moiety, the coordination number at the metal (L = 4-ethylisonicotinate or a vacant coordination site) and the substituent R (R = nbutyl, phenyl, 1-pyrenyl) have been varied. Structures of the enynyl complex Ru(CO)Cl(PPh3)2(eta1:eta2-nBuHC=CHCCnB...

Spontaneous formation of ruthenium nanochains is accomplished in aqueous medium under mild conditions using a seed mediated protocol with cetyl trimethylammonium bromide (CTAB) as the capping agent. They are formed due to the random self-assembly of Ru seeds of ∼3.5 nm size. These 1D nanostructures exhibit better catalytic activity towards the oxidation of CO relative to the ∼3.5 nm seeds and 6...

In recent years, the field of metal-based drugs has been dominated by other existing precious metal drugs, and many researchers have focused their attention on the synthesis of various ruthenium (Ru) complexes due to their potential medical and pharmaceutical applications. The beneficial properties of Ru, which make it a highly promising therapeutic agent, include its variable oxidation states,...

Dioxoruthenium(VI) porphyrins including those containing chiral porphyrinato ligands can be readily prepared by oxidation of [RuII(Por)(CO)(MeOH)] with PhIO or metachloroperoxybenzoic acid. Similar reactions with PhINTs gave [Ru(Por)(NTs)2] isolated as air stable solids at room temperature. The [Ru(Por)O2] complexes are competent oxidants for epoxidation of alkenes with high selectivities. Enan...

Reaction of [RuVI(N)(L1)(MeOH)]+ (L1 ) N,N′-bis(salicylidene)-o-cyclohexylenediamine dianion) with excess pyridine in CH3CN produces [Ru(L)(py)2] and N2. The proposed mechanism involves initial equilibrium formation of [RuVI(N)(L1)(py)]+, which undergoes rapid N · · · N coupling to produce [(py)(L1)RuIIINtN-RuIII(L1)(py)]2+; this is followed by pyridine substituion to give the final product. Th...

The O/Ru(0001) system is widely studied due to its rich phase variety of various stoichiometry and atomic arrangements, including the formation of a RuO2/Ru(0001) oxide layer. Apart from homogeneous ruthenium surfaces in certain oxidation states, also strongly heterogeneous surfaces can exist due to oxidation state's variation at the nanoscale. We report on a scanning tunneling microscopy (STM)...

The title compound, [Ru(3)(C(12)H(12)N)(3)(CO(3))(C(6)H(6))(3)]PF(6)·CH(2)Cl(2), was obtained unintentionally as the product of an attempted deprotonation of the monomeric parent ruthenium complex [Ru(C(12)H(12)N)(C(6)H(6))(C(2)H(3)N)]PF(6). The carbonate ligand bridges three half-sandwich cyclo-ruthenated fragments, each of them exhibiting a pseudo-tetra-hedral geometry. The configuration of t...